URO1 Inc., which is developing medical products for urology procedures, has raised $1.1 million in an equity offering, according to a filing Monday with the Securities and Exchange Commission.

The company raised the money from nine investors.

URO 1 has offered $2.9 million and $1.8 million remains to be sold.

Ted Belleza has served as CEO and president since April 2017. The chief technology officer of the company is Jack Snoke.

Snoke has received more than 40 patents for medical devices, which he’s been designing since he graduated from Georgia Institute of Technology in 1978. He built a previous company, Surgical Endoscopy Systems, around new products for obstetrics and gynecology doctors.

Companies relying on a Reg D exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after they first sell their securities.